Viper venom Polypeptides and variants
    1.
    发明公开
    Viper venom Polypeptides and variants 失效
    Vi蛇毒多肽和变种

    公开(公告)号:EP0382451A3

    公开(公告)日:1991-05-29

    申请号:EP90301181.5

    申请日:1990-02-05

    IPC分类号: C07K7/10 A61K37/02

    CPC分类号: C07K14/46 A61K38/00

    摘要: A platelet aggregation inhibiting polypeptide having the following amino acid sequence:
    X-Cys-R-R-R-Arg-Gly-Asp-R-R-R-R-R-Cys-Y
    wherein X is H or at least one amino acid; Y is OH or at least one amino acid; and each R, either the same or different, is any amino acid. Polypeptides having this sequence are potent inhibitors of fibrinogen binding to receptors expressed on the glycoprotein IIb/IIIa complex in the membrane of platelets, and are therefore potent inhibitors of fibrinogen-induced human platelet aggregation. They are useful in inhibition of platelet aggregation formation.

    摘要翻译: 具有下列氨基酸序列的血小板聚集抑制多肽:X-Cys-R-R-R-Arg-Gly-Asp-R-R-R-R-R-Cys-Y其中X是H或至少一个氨基酸; Y是OH或至少一个氨基酸; 并且每个R,相同或不同,是任何氨基酸。 具有该序列的多肽是纤维蛋白原与血小板膜中糖蛋白IIb / IIIa复合物上表达的受体结合的有效抑制剂,因此是纤维蛋白原诱导的人血小板聚集的有效抑制剂。 它们可用于抑制血小板聚集形成。

    Viper venom Polypeptides and variants
    2.
    发明公开
    Viper venom Polypeptides and variants 失效
    多肽和deren变种aus dem礼物冯Schlangen。

    公开(公告)号:EP0382451A2

    公开(公告)日:1990-08-16

    申请号:EP90301181.5

    申请日:1990-02-05

    IPC分类号: C07K7/10 A61K37/02

    CPC分类号: C07K14/46 A61K38/00

    摘要: A platelet aggregation inhibiting polypeptide having the following amino acid sequence:
    X-Cys-R-R-R-Arg-Gly-Asp-R-R-R-R-R-Cys-Y
    wherein X is H or at least one amino acid; Y is OH or at least one amino acid; and each R, either the same or different, is any amino acid.
    Polypeptides having this sequence are potent inhibitors of fibrinogen binding to receptors expressed on the glycoprotein IIb/IIIa complex in the membrane of platelets, and are therefore potent inhibitors of fibrinogen-induced human platelet aggregation. They are useful in inhibition of platelet aggregation formation.

    摘要翻译: 具有以下氨基酸序列的血小板聚集抑制多肽:X-Cys-R-R-R-Arg-Gly-Asp-R-R-R-R-R-Cys-Y,其中X为H或至少一个氨基酸; Y是OH或至少一个氨基酸; 并且每个R相同或不同,是任何氨基酸。 具有该序列的多肽是与血小板膜上的糖蛋白IIb / IIIa复合体上表达的受体结合的纤维蛋白原的有效抑制剂,因此是纤维蛋白原诱导的人血小板聚集的有效抑制剂。 它们可用于抑制血小板聚集形成。

    Trigramin- a platelet aggregation inhibiting polypeptide
    3.
    发明公开
    Trigramin- a platelet aggregation inhibiting polypeptide 失效
    Trigramin,ein Polypeptid,das die Aggregation derBlutplättchenhemmt。

    公开(公告)号:EP0317053A2

    公开(公告)日:1989-05-24

    申请号:EP88307818.0

    申请日:1988-08-24

    IPC分类号: C07K7/10 A61K37/64

    CPC分类号: C07K14/46 A61K38/00

    摘要: Trigramin, a 72-amino acid polypeptide, has the following amino acid sequence: EAGEDCDCGSPANPCCDA­ATCKLIPGAQCGEGLCCDQCSFIEEGTVCRIARGDDLDDYCNGRSAGCPRNPFH. The molecule is a potent inhibitor of fibrinogen binding to receptors expressed on the glycoprotein IIb/IIIa complex in the membrane of platelets. Trigramin is thus a potent inhibitor of fibrinogen-induced human platelet aggregation. It is useful in inhibiting the formation of hemostatic platelet plugs.

    摘要翻译: 特拉曲林是一个72个氨基酸的多肽,具有以下氨基酸序列:EAGEDCDCGSPANPCCDAATCKLIPGAQCGEGLCCDQCSFIEEGTVCRIARGDDLDDYCNGRSAGCPRNPFH。 该分子是与血小板膜上的糖蛋白IIb / IIIa复合体上表达的受体结合的纤维蛋白原的有效抑制剂。 因此,Trigramin是纤维蛋白原诱导的人血小板聚集的有效抑制剂。 它可用于抑制止血血小板塞的形成。